Shree Ganesh Bio-Tech Complete Financial Statements
In FY2026, Shree Ganesh Bio-Tech (SHREEGANES) reported revenue ₹5 Cr, net profit ₹0 Cr and EPS ₹0.01. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore SHREEGANES value investing to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SHREEGANES Revenue, Net Profit & EBITDA — Year-on-Year Growth
SHREEGANES YoY (March 2025 vs March 2026) — revenue -79.2%, expenses -75.0%. Review SHREEGANES P/E comparison to evaluate earnings-based valuation against sector peers.
SHREEGANES Income Statement — Revenue, EBITDA & Net Profit
Shree Ganesh Bio-Tech revenue ₹5 Cr, EBITDA ₹-1 Cr, net profit ₹0 Cr, EPS ₹0.01 (2026). For live price, earnings ratios and company overview, see SHREEGANES share price.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 24 | 21 | 63 | 73 | 17 | 3 | 6 | 8 | 9 | 2 | 2 |
| Expenses | 6 | 24 | 21 | 60 | 69 | 17 | 2 | 4 | 4 | 5 | 2 | 1 |
| EBITDA | -1 | 0 | 1 | 3 | 4 | 1 | 0 | 2 | 4 | 4 | 1 | 1 |
| Operating Profit Margin % | -19.00% | -5.00% | -1.00% | 3.00% | 5.00% | 4.00% | 10.00% | 31.00% | 45.00% | 44.00% | 31.00% | 30.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 0 | 1 | 3 | 4 | 0 | 0 | 2 | 4 | 4 | 1 | 0 |
| Tax | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 1 | 2 | 3 | 0 | 0 | 2 | 4 | 4 | 1 | 0 |
| Earnings Per Share (₹) | 0.01 | 0.01 | 0.02 | 0.05 | 0.13 | 0.16 | 0.12 | 0.90 | 19.12 | 20.39 | 2.94 | 1.88 |
SHREEGANES Balance Sheet — Assets, Liabilities & Shareholders' Equity
SHREEGANES total assets ₹64 Cr, total equity ₹64 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 64 | 64 | 74 | 80 | 94 | 75 | 65 | 64 | 26 | 19 | 5 | 5 |
| Current Assets | 12 | 3 | 4 | 20 | 44 | 28 | 21 | 19 | 14 | 9 | 3 | 2 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 12 | 9 | 0 | 0 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 54 | 74 | 80 | 90 | 72 | 65 | 64 | 26 | 19 | 3 | 3 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 64 | 63 | 63 | 62 | 60 | 58 | 58 | 57 | 23 | 19 | 5 | 4 |
| Share Capital | 40 | 40 | 40 | 40 | 20 | 20 | 20 | 20 | 2 | 2 | 2 | 2 |
| Reserves & Surplus | 24 | 23 | 23 | 23 | 40 | 38 | 38 | 37 | 10 | 7 | 3 | 2 |
SHREEGANES Cash Flow Statement — Operating, Investing & Financing
Shree Ganesh Bio-Tech operating cash flow ₹-10 Cr, investing ₹10 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -10 | 10 | 11 | 4 | 2 | -1 | -1 | 2 | -13 | 0 | 0 |
| Investing Activities | 10 | -10 | -10 | -3 | -2 | 1 | -32 | -2 | 3 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 0 | 10 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |